{"id":10147,"date":"2023-01-06T07:00:00","date_gmt":"2023-01-06T06:00:00","guid":{"rendered":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-6e-neuroscience-innovation-forum-i-san-francisco-den-8-januari-2023\/"},"modified":"2023-01-06T07:00:00","modified_gmt":"2023-01-06T06:00:00","slug":"irlab-presenterar-pa-6e-neuroscience-innovation-forum-i-san-francisco-den-8-januari-2023","status":"publish","type":"mfn_news","link":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-6e-neuroscience-innovation-forum-i-san-francisco-den-8-januari-2023\/","title":{"rendered":"IRLAB presenterar p\u00e5 6:e Neuroscience Innovation Forum i San Francisco den 8 januari 2023"},"content":{"rendered":"<p>[mfn_before_post]<\/p>\n<div class=\"mfn-preamble\">\n<p><strong>G\u00f6teborg, Sverige, 6 januari 2023 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett bolag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r de mest besv\u00e4rliga symtomen vid Parkinsons sjukdom, meddelade idag att bolaget deltar p\u00e5 det 6:e Neuroscience Innovation Forum som anordnas av Sachs Associates. Eventet h\u00e5lls p\u00e5 s\u00f6ndagen den 8 januari 2023 i San Fransisco, USA, i samband med den \u00e5rliga J.P. Morgan Healthcare Conference.<\/strong><\/p>\n<\/div>\n<div class=\"mfn-body\">\n<p>Richard Godfrey, VD p\u00e5 IRLAB, kommer att delta i en paneldiskussion om titulerad \u201dNew Approaches to Parkinson\u2019s and Movement Disorders\u201d tillsammans med panellister fr\u00e5n Rune Labs, Inc., Ipsen, Alterity Therapeutics och The Michael J. Fox Foundation for Parkinson\u2019s Research. Panelen leds av Cheryl Zimberlin, Investment Director, M Ventures och Jay Olson, Managing Director &amp; Senior Analyst, Oppenheimer &amp; Co. Inc. En bolagspresentation kommer \u00e4ven att h\u00e5llas p\u00e5 eventet.<\/p>\n<p>Det 6:e Neuroscience Innovation Forum (\u00e4ven kallat 6:e NIF) \u00e4r ett fysiskt event som h\u00e5lls p\u00e5 Memorial Club, San Francisco, den 8 januari 2023, en dag f\u00f6re den 41:a \u00e5rliga J.P. Morgan Healthcare Conference. Huvudprogrammet f\u00f6r det 6:e Neuroscience Innovation Forum inneh\u00e5ller mer \u00e4n 10 timmar av keynotes och paneldiskussioner om den senaste utvecklingen inom globalt biopartnerskap och investeringar, med ytterligare paneler om vetenskapliga framsteg inom viktiga terapeutiska omr\u00e5den av neurodegenerativa sjukdomar samt mer generellt om CNS, vilket omfattar neuropsykiatri, oftalmologi, neurotech och digitala behandlingar. M\u00e5lgruppen inkluderar analytiker p\u00e5 k\u00f6p- och s\u00e4ljsidan fr\u00e5n investeringsbanker och fonder, personer i ledande positioner inom partnerskap fr\u00e5n l\u00e4kemedels-, bioteknik- och medicinteknikf\u00f6retag. Eventet f\u00f6rv\u00e4ntas ha \u00f6ver 250 delegater och \u00f6ver 30 olika bolagspresentationer av etablerade och lovande bolag med en del av publiken som deltar virtuellt.<\/p>\n<p>Mer information finns p\u00e5 eventets webbplats: <a href=\"https:\/\/www.sachsforum.com\/6nif-about.html\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/www.sachsforum.com\/6nif-about.html<\/a>.<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-3931160317df\">\n<p><strong class=\"mfn-heading-1\">F\u00f6r mer information:<\/strong><\/p>\n<hr \/>\n<p>Richard Godfrey, VD<br \/>Telefon: +46 730 70 69 00<br \/>E-mail:\u00a0<a href=\"mailto:richard.godfrey@irlab.se\" target=\"_blank\" rel=\"nofollow noopener\">richard.godfrey@irlab.se<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about mfn-a19a8f82b785\">\n<p><strong class=\"mfn-heading-1\">Om IRLAB<\/strong><\/p>\n<hr \/>\n<p>IRLAB uppt\u00e4cker och utvecklar nya l\u00e4kemedel f\u00f6r behandling av Parkinsons sjukdom och andra sjukdomar i hj\u00e4rnan. Bolagets l\u00e4ngst framskridna l\u00e4kemedelskandidater, mesdopetam (IRL790) och pirepemat (IRL752) \u00e4r b\u00e5da i Fas IIb och \u00e4r designade f\u00f6r att behandla n\u00e5gra av de sv\u00e5raste symtomen relaterade till Parkinson. \u00c5r 2021 f\u00f6rv\u00e4rvade Ipsen, ett specialty pharma-bolag, de exklusiva globala r\u00e4ttigheterna till utveckling och kommersialisering av mesdopetam.<br \/>\u00a0<br \/>IRLAB har genererat alla sina l\u00e4kemedelskandidater och forts\u00e4tter att uppt\u00e4cka innovativa l\u00e4kemedelskandidater f\u00f6r behandling av neurologiska sjukdomar genom den egenutvecklade forskningsplattformen ISP (Integrative Screening Process). F\u00f6rutom IRLAB:s starka kliniska pipeline driver bolaget tv\u00e5 prekliniska program, IRL942 och IRL757, mot Fas I-studier. IRLAB \u00e4r noterat p\u00e5 Nasdaq Stockholm. Mer information p\u00e5\u00a0<a target=\"_blank\" href=\"http:\/\/www.irlab.se.\/\" rel=\"nofollow noopener\">www.irlab.se.<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p><strong class=\"mfn-heading-1\">Bifogade filer<\/strong><\/p>\n<hr \/>\n<p><a class=\"mfn-generated mfn-primary\" href=\"https:\/\/storage.mfn.se\/bd977f11-7f8e-4a2d-a783-55d1f582bd6d\/irlab-presenterar-pa-6-e-neuroscience-innovation-forum-i-san-francisco-den-8-januari-2023.pdf\" target=\"_blank\" rel=\"nofollow noopener\">IRLAB presenterar p\u00e5 6:e Neuroscience Innovation Forum i San Francisco den 8 januari 2023<\/a><\/p>\n<\/div>\n<p>[mfn_after_post]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>G\u00f6teborg, Sverige, 6 januari 2023 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett bolag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r de mest besv\u00e4rliga symtomen vid Parkinsons sjukdom, meddelade idag att bolaget deltar p\u00e5 det 6:e Neuroscience Innovation Forum som anordnas av Sachs Associates. Eventet h\u00e5lls p\u00e5 s\u00f6ndagen den 8 januari 2023 i San Fransisco, USA, i samband med den \u00e5rliga J.P. Morgan Healthcare Conference.<\/p>\n","protected":false},"template":"","class_list":["post-10147","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>IRLAB presenterar p\u00e5 6:e Neuroscience Innovation Forum i San Francisco den 8 januari 2023 - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-6e-neuroscience-innovation-forum-i-san-francisco-den-8-januari-2023\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB presenterar p\u00e5 6:e Neuroscience Innovation Forum i San Francisco den 8 januari 2023 - IRLAB\" \/>\n<meta property=\"og:description\" content=\"G\u00f6teborg, Sverige, 6 januari 2023 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett bolag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r de mest besv\u00e4rliga symtomen vid Parkinsons sjukdom, meddelade idag att bolaget deltar p\u00e5 det 6:e Neuroscience Innovation Forum som anordnas av Sachs Associates. Eventet h\u00e5lls p\u00e5 s\u00f6ndagen den 8 januari 2023 i San Fransisco, USA, i samband med den \u00e5rliga J.P. Morgan Healthcare Conference.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-6e-neuroscience-innovation-forum-i-san-francisco-den-8-januari-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-6e-neuroscience-innovation-forum-i-san-francisco-den-8-januari-2023\/\",\"url\":\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-6e-neuroscience-innovation-forum-i-san-francisco-den-8-januari-2023\/\",\"name\":\"IRLAB presenterar p\u00e5 6:e Neuroscience Innovation Forum i San Francisco den 8 januari 2023 - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2023-01-06T06:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-6e-neuroscience-innovation-forum-i-san-francisco-den-8-januari-2023\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-6e-neuroscience-innovation-forum-i-san-francisco-den-8-januari-2023\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-6e-neuroscience-innovation-forum-i-san-francisco-den-8-januari-2023\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\/\/irlab.se\/sv\/pressmeddelanden\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IRLAB presenterar p\u00e5 6:e Neuroscience Innovation Forum i San Francisco den 8 januari 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson&#039;s disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB presenterar p\u00e5 6:e Neuroscience Innovation Forum i San Francisco den 8 januari 2023 - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-6e-neuroscience-innovation-forum-i-san-francisco-den-8-januari-2023\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB presenterar p\u00e5 6:e Neuroscience Innovation Forum i San Francisco den 8 januari 2023 - IRLAB","og_description":"G\u00f6teborg, Sverige, 6 januari 2023 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett bolag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r de mest besv\u00e4rliga symtomen vid Parkinsons sjukdom, meddelade idag att bolaget deltar p\u00e5 det 6:e Neuroscience Innovation Forum som anordnas av Sachs Associates. Eventet h\u00e5lls p\u00e5 s\u00f6ndagen den 8 januari 2023 i San Fransisco, USA, i samband med den \u00e5rliga J.P. Morgan Healthcare Conference.","og_url":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-6e-neuroscience-innovation-forum-i-san-francisco-den-8-januari-2023\/","og_site_name":"IRLAB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-6e-neuroscience-innovation-forum-i-san-francisco-den-8-januari-2023\/","url":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-6e-neuroscience-innovation-forum-i-san-francisco-den-8-januari-2023\/","name":"IRLAB presenterar p\u00e5 6:e Neuroscience Innovation Forum i San Francisco den 8 januari 2023 - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2023-01-06T06:00:00+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-6e-neuroscience-innovation-forum-i-san-francisco-den-8-januari-2023\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-6e-neuroscience-innovation-forum-i-san-francisco-den-8-januari-2023\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-6e-neuroscience-innovation-forum-i-san-francisco-den-8-januari-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/irlab.se\/sv\/pressmeddelanden\/"},{"@type":"ListItem","position":3,"name":"IRLAB presenterar p\u00e5 6:e Neuroscience Innovation Forum i San Francisco den 8 januari 2023"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson&#039;s disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news\/10147","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=10147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}